Meanwhile, within the TUFT1 high-expression group, patients with hyperphosphorylated TUFT1 exhibited reduced OS (Fig. 7F), implying that for the entire breast cancer cell population, the disadvantage of TUFT1 hyperphosphorylation on cell proliferation may be overcome by its advantage of increasing CA and CIN. This evidence concerns the gene TUFT1 and breast carcinoma.